Hello all, I received a 4-year AFROTC scholarship during my senior year of high school (which I just finished) but unfortunately was denied a medical waiver because I'm not >2 years in remission for a very minor jaw problem (which I'm pretty sure is a rule that was made up on the spot, but I digress). Anyway, I will unfortunately have to enter college as a non-scholarship AFROTC cadet, try to win a scholarship, and go through the DoDMERB process again in two years. Not the outcome I was hoping for, but I guess adversity makes you stronger. Anyway, my first question is: my remission started in November 2014. So I will be eligible to get a waiver starting in Nov 2016. When are selections for Field Training made? If I am chosen for Field Training, I will have to once again confront the beast that is DoDMERB. Would being eligible for a waiver in late 2016 affect my ability to attend field training (which for me would be summer 2017)? On that note, would strong performance in ROTC my first two years of college improve my chances of receiving a medical waiver in the future? It's important to note that this condition has literally never affected me in any way. I play football, box recreationally, etc... I don't even see a doctor for it or take any meds. Assuming that all stays the same and I am a good ROTC participant, will it help my case? Sorry for the multiple medical-related questions. My other question is regarding the Project GO language program. I'm a technical major but I have a strong interest in languages and plan to take two in college. Would not being on ROTC scholarship affect my chances of being able to get a Project GO scholarship? Thank you for your responses. Obviously, I'm bummed with the Air Force's decision regarding my waiver. I was surprised to hear them deny it, because they earlier requested a remedial blood test which I passed in every way. Anyhow, I guess this will be a test of character. I'm not guaranteed a waiver in two years, but I will do everything I can to show the Air Force that I deserve one.